| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4250192 | Revista Española de Medicina Nuclear e Imagen Molecular | 2017 | 7 Pages |
Abstract
FDG-PET/CT after the first cycles of chemotherapy is useful to monitor treatment due to its high negative predictive value (87.5%), using it to modify treatment early in the non-responders.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
M. Cortés Romera, C. Gámez Cenzano, A.P. Caresia Aróztegui, J. MartÃn-ComÃn, E. González-Barca, Y. Ricart Brulles, A. Palacios Abufón, J. Robles Barba, L. RodrÃguez-Bel, S. Rossi Seoane, A. Fernández de Sevilla,